We serve Chemical Name:2-(Iodomethyl)oxetane CAS:121138-00-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Iodomethyl)oxetane
CAS.NO:121138-00-9
Synonyms:Oxetane, 2-(iodomethyl)-;2-(Iodomethyl)oxetane
Molecular Formula:C4H7IO
Molecular Weight:198.002
HS Code:2932999099
Physical and Chemical Properties:
Melting point:N/A
Boiling point:187.3±13.0 °C at 760 mmHg
Density:1.9±0.1 g/cm3
Index of Refraction:1.563
PSA:9.23000
Exact Mass:197.954147
LogP:0.91
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Oxetane, 2-(iodomethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Iodomethyl)oxetane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Oxetane, 2-(iodomethyl)- Use and application,Oxetane, 2-(iodomethyl)- technical grade,usp/ep/jp grade.
Related News: A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 2-(Iodomethyl)oxetane manufacturer The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 2-(Iodomethyl)oxetane supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 2-(Iodomethyl)oxetane vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-(Iodomethyl)oxetane factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).
